S100A4 and osteosarcoma: We have previously shown, using a specific ribozyme transfected into highly metastatic S100A4 expressing human osteosarcoma cells, that reduced expression of S100A4 leads to a nearly complete reversal of the metastatic phenotype in an animal model (Mælandsmo et al, 1996).